Clinical Trials Logo

Overweight clinical trials

View clinical trials related to Overweight.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT06371326 Enrolling by invitation - Clinical trials for Overweight or Obesity

A Study of ZT002 Injection in Participants With Overweight or Obesity

Start date: November 21, 2023
Phase: Phase 1
Study type: Interventional

This study will comprise a randomized, double-blind, placebo-controlled, multiple-ascending-dose, safety, tolerability, and pharmacokinetics study of ZT002 in participants with Overweight or Obesity.

NCT ID: NCT06092632 Enrolling by invitation - Dyslipidemias Clinical Trials

Efficacy of Pigmented Rice on Reducing Cardiometabolic Risk Factors Among Filipino Adults

Start date: October 13, 2023
Phase: N/A
Study type: Interventional

The primary purpose of this clinical trial is to investigate whether the consumption of pigmented rice (black rice) in the diet improves cardiovascular health, specifically body weight, lipids, and glucose levels. It also aims to know whether people enjoyed eating pigmented rice and if they would continue eating it.

NCT ID: NCT05873660 Enrolling by invitation - Obesity Clinical Trials

A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease.

POETIC
Start date: June 12, 2023
Phase:
Study type: Observational

The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across the globe representing different geographies, ethnicities, as well as different healthcare systems.

NCT ID: NCT05872022 Enrolling by invitation - Obesity Clinical Trials

A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy

Start date: July 5, 2023
Phase:
Study type: Observational

This is an observational, prospective Wegovy (semaglutide 2.4 milligram [mg]) Pregnancy Registry Study. The aim of this study is to compare the maternal, foetal, and infant outcomes of pregnant women who are exposed to Wegovy during pregnancy for the treatment of obesity or overweight with at least one weight-related comorbid condition with outcomes in an internal comparison cohort of pregnant women with obesity or overweight with at least one weight related comorbid condition at conception and who are not exposed to Wegovy or other glucagon-like peptide-1 receptor agonists (GLP-1 RAs) during pregnancy. Infant outcomes will be assessed throughout the infant's first year of life, with active data collection by the registry occurring at 4 and 12 months after delivery.

NCT ID: NCT05868954 Enrolling by invitation - Diet, Healthy Clinical Trials

Implementation of a Mediterranean Diet Program for Overweight or Obese Pregnant Women in a Low-resource Clinical Setting

MedDiet
Start date: August 31, 2023
Phase: N/A
Study type: Interventional

The purpose of this research is to compare two healthy diet styles during pregnancy. Sixty pregnant women between 8 and 16 weeks will participate. Participates will be randomly assigned (like flipping a coin) to either receive routine healthy diet advice and counseling, or to receive advice and counseling for the Mediterranean style diet. Our current routine healthy diet program follows the recommendations provided by the American College of Obstetricians and Gynecologists (ACOG). It recommends the consumption of grains, fruits, vegetables, protein foods, and dairy foods during pregnancy. The Mediterranean diet (MedDiet) is a well-known healthy diet that consists of a large amount of plant-based foods such as fruits, vegetables, beans, and nuts with olive oil as the principal source of fat. Dairy, fish, and poultry are consumed in moderation and red meat only eaten occasionally. Throughout their pregnancy, participants will receive free food and be assessed to determine how will they are following to the diet plan they were randomized to.

NCT ID: NCT05826379 Enrolling by invitation - Clinical trials for Overweight and Obesity

Daily Goal Setting to Increase Everyday Physical Activity and Promote Cognitive Health in Midlife

Start date: March 20, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether interaction with an adaptive Fitbit-based goal setting application can increase levels of everyday light intensity physical activity in middle-aged adults.

NCT ID: NCT05660291 Enrolling by invitation - Overweight Clinical Trials

A Study of Time Restricted Eating in Obese Adults

Start date: February 24, 2023
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to understand the difference between early and late time-restricted eating on weight and body mass index (BMI), and evaluate the barriers encountered and the effect on quality of life.

NCT ID: NCT05640414 Enrolling by invitation - Obesity Clinical Trials

Weekly Family Food Packages: Food is Medicine

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The specific aims and objectives of this proposal are to: 1. Evaluate a food pantry's weekly food distribution impact on behavioral, social and health outcomes in families. 2. In a subset of families with a child aged 6-17 years, test a pilot intervention offering the following components, with a goal of improving family behavioral, social and health outcomes: 1. Weekly family food packages from the Revere Food Pantry 2. 6-Monthly group sessions that include information on healthy behaviors, chronic disease management and teaching families how to prepare simple recipes based on the food they receive that week from the food pantry.

NCT ID: NCT05576116 Enrolling by invitation - Clinical trials for Diabetes Mellitus, Type 2

Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics

ComB-PAK
Start date: September 23, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the effectiveness of sleeve gastrectomy combined with pancreas after kidney (PAK) transplantation as a means of achieving normoglycemia, insulin independence, reduced insulin resistance, and kidney graft function preservation in the T2DM population. in the first year post pancreas after kidney transplant. Safety and efficacy data will be collected from the time of enrollment until participants reach 1 year post PAK transplant. Data will be compared to historical data from TGH's renal and pancreas transplant programs.

NCT ID: NCT05554601 Enrolling by invitation - Obesity Clinical Trials

A Randomized Trial of Behaviorally Designed Gamification and Social Incentives to Increase Physical Activity Among Overweight and Obese Veterans

STEP 4 Vets
Start date: July 17, 2023
Phase: N/A
Study type: Interventional

Despite the many associated health benefits, more than half of Veterans do not achieve enough regular physical activity. The investigators' prior work has demonstrated that gamification, a method commonly used for health promotion, can lead to sustained increases in physical activity if it is designed using insights from behavioral economics to enhance social incentives. In this study, the investigators will compare the effectiveness of behaviorally designed gamification that encourages Veterans to collaborate or compete on physical activity levels and examine clinical outcomes as well as costs, barriers and facilitators to implementation of the program within Veterans Affairs.